Literature DB >> 33389324

Electronic Adherence Monitoring May Facilitate Intentional HIV Status Disclosure Among People Living with HIV in Rural Southwestern Uganda.

Angella Musiimenta1,2, Jeffrey I Campbell3, Wilson Tumuhimbise4, Bridget Burns5, Esther C Atukunda4, Nir Eyal6, Jessica E Haberer5.   

Abstract

HIV status disclosure remains one of the major challenges to effective HIV prevention. Given the complexities and low rates of disclosure, new innovative strategies are needed. Since electronic adherence monitoring (EAM) are unique mobile devices that light up when transmitting data, those who see them often want to know more about them, which can potentially result in HIV status disclosure. We conducted a qualitative study to explore patient experiences with EAM for antiretroviral therapy (ART) in Uganda with a goal of understanding potential ethical concerns, including disclosure. Unexpectedly, several participants reported intentionally using EAM to facilitate HIV status disclosure to others in order to get social support, encourage HIV testing, and create awareness about HIV. Although researchers and clinicians need to be mindful of the potential for unintended HIV status disclosure through the use of EAM, they should also recognize the potential of this approach to support intended disclosure.

Entities:  

Keywords:  Adherence; Electronic; HIV intentional disclosure; Uganda

Mesh:

Year:  2021        PMID: 33389324      PMCID: PMC8778960          DOI: 10.1007/s10461-020-03143-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  3 in total

Review 1.  Secrets and safety in the age of AIDS: does HIV disclosure lead to safer sex?

Authors:  Jane M Simoni; David W Pantalone
Journal:  Top HIV Med       Date:  2004 Oct-Nov

2.  "I DIDN'T TELL YOU SOONER BECAUSE I DIDN'T KNOW HOW TO HANDLE IT MYSELF." DEVELOPING A VIRTUAL REALITY PROGRAM TO SUPPORT HIV-STATUS DISCLOSURE DECISIONS.

Authors:  Kathryn E Muessig; Kelly A Knudtson; Karina Soni; Margo Adams Larsen; David Traum; Willa Dong; Donaldson F Conserve; Anton Leuski; Ron Artstein; Lisa B Hightow-Weidman
Journal:  Digit Cult Educ       Date:  2018-07-13

3.  Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.

Authors:  Jessica E Haberer; Nicholas Musinguzi; Yap Boum; Mark J Siedner; A Rain Mocello; Peter W Hunt; Jeffrey N Martin; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

  3 in total
  1 in total

1.  "The research assistants kept coming to follow me up; I counted myself as a lucky person": Social support arising from a longitudinal HIV cohort study in Uganda.

Authors:  Jeffrey I Campbell; Angella Musiimenta; Sylvia Natukunda; Nir Eyal; Jessica E Haberer
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.